Gulf Pharmaceutical Industries P.S.C. financials at a glance

+ Portfolio

The revenue of Gulf Pharmaceutical Industries P.S.C. is reported as 1.6161 billion in the fiscal year 2023. The earnings were -0.02 per share in 2023, which was 0 higher than 2022. And about 0.0193 billion are reported as free cash flow in the financials of Gulf Pharmaceutical Industries P.S.C. 2023. No dividends were paid to the shareholders of the Gulf Pharmaceutical Industries P.S.C. stock ADX:JULPHAR in the financial year 2023.

1.62B

Revenue

-0.02

Earnings Per Share

100.00%

Gross Margin %

-90.50M

Free Cash Flow

Revenue

1,616.10

Earnings Per Share

-0.02

Gross Margin %

100.00

Free Cash Flow

-90.50

Financials

Year	Year	TTM	2023	2022	2018	2017	2016	2014	2013
Rev.	Revenue	N/A	1.62B	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
GM %	Gross Margin %	27.94%	100.00%	30.85%	21.26%	45.73%	60.72%	58.97%	60.25%
OM	Operating Margin	-5.97%	-1.87%	-1.77%	-35.75%	7.91%	12.68%	14.67%	16.44%
EPS	Earnings Per Share	-0.11	-0.02	-0.02	-0.94	0.14	0.32	0.37	0.37
Div.	Dividends	N/A	0.01	0.01	0.00	0.17	0.27	0.23	0.00
PR %	Payout Ratio %	0	-50.00%	-50.00%	-0.00%	121.43%	84.38%	62.16%	0
Sha.	Shares	N/AM	1,155.23M	1,155.23M	655.23M	655.25M	655.23M	655.23M	622.12M
OCF	Operating Cash Flow	N/A	19.30M	19.30M	179.80M	82.40M	267.60M	41.60M	0.00M
FCF	Free Cash Flow	N/A	-90.50M	-44.40M	150.80M	-5.10M	164.50M	-39.58M	0.00M
FCFS	Free Cash Flow Per Share	-0.01	0.00	-0.04	0.19	-0.01	0.25	-0.06	0.03

Gulf Pharmaceutical Industries P.S.C. financials at a glance

Financials

Discover